The benefit of HER2 targeted therapies on overall survival of patients with metastatic HER2+ breast cancer – a systematic review

Mendes D, Alves C, Afonso N, Cardoso F, Passos-Coelho J, Costa L, Andrade S, Batel Marques F

Breast Cancer Research

2015